BIA
DGX icon

Bell Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bell Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Sell
310
-5
-2% -$981 0.01% 233
2026
Q1 		$61.7K Buy
315
+3
+1% +$583 0.01% 226
2025
Q4 		$54.1K Sell
312
-7
-2% -$1.27K 0.01% 245
2025
Q3 		$60.8K Hold
319
– – 0.01% 219
2025
Q2 		$57.3K Buy
319
+142
+80% +$24.7K 0.01% 226
2025
Q1 		$29.9K Hold
177
– – 0.01% 297
2024
Q4 		$26.7K Sell
177
-6
-3% -$933 0.01% 322
2024
Q3 		$28.4K Sell
183
-4
-2% -$597 0.01% 324
2024
Q2 		$25.6K Buy
187
+67
+56% +$9.18K 0.01% 336
2024
Q1 		$16K Sell
120
-54
-31% -$7.01K ﹤0.01% 430
2023
Q4 		$24K Sell
174
-22
-11% -$2.89K ﹤0.01% 319
2023
Q3 		$23.9K Buy
196
+31
+19% +$4.13K 0.01% 276
2023
Q2 		$23.2K Buy
165
+24
+17% +$3.31K 0.01% 285
2023
Q1 		$19.9K Sell
141
-26
-16% -$3.72K ﹤0.01% 305
2022
Q4 		$26.1K Buy
167
+38
+29% +$5.46K 0.01% 253
2022
Q3 		$16K Sell
129
-10
-7% -$1.32K 0.01% 297
2022
Q2 		$18K Buy
+139
New +$18.9K 0.01% 280
2021
Q4 		$26K Buy
149
+11
+8% +$1.67K 0.01% 255
2021
Q3 		$20K Buy
+138
New +$20.2K 0.01% 284

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Bell Investment Advisors's DGX Position: Q2 2026 in Review

Bell Investment Advisors reduced its Quest Diagnostics (DGX) stake by 1.6% in Q2 2026, selling an estimated $981 and leaving 310 shares worth $65.7K. The position accounts for 0.01% of the portfolio, ranked #233.

Bell Investment Advisors first reported a position in DGX in Q3 2021 and has held it in 19 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Bell Investment Advisors held 310 shares of Quest Diagnostics worth $65.7K as of Q2 2026.
  • Bell Investment Advisors sold 5 Quest Diagnostics shares in Q2 2026, an estimated $981.
  • Quest Diagnostics made up 0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #233 holding.
  • Bell Investment Advisors first reported a position in Quest Diagnostics in Q3 2021 and has held it in 19 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.